/PRNewswire/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company"), TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) is pleased to announce that, effective January 1,.
/PRNewswire/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company"), TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) is pleased to announce that, effective January 1,.
Hosting Call at 5pm ET on Thursday, November 18th Nanalysis Scientific Corp. a leader in portable MRI and NMR machines for healthcare and industrial applications, announces that on Thursday, November 18, 2021 the Company will release financial results for its third quarter 2021 after the market closes on Thursday November 18, 2021 . Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Luke Caplette .
Nanalysis Scientific Corp. is pleased to announce that it has received conditional acceptance from the TSX Venture Exchange to make a Normal Course Issuer Bid to purchase for cancellation, during the 12-month period starting October 25, 2021 up to 3,844,081 of the Common Shares, representing 5% of the Common Shares outstanding as of October 25 2021. The program will end on October 24, 2022 the maximum amount of .